Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
3.280
-0.190 (-5.48%)
At close: Jun 27, 2025, 4:00 PM
3.220
-0.060 (-1.83%)
After-hours: Jun 27, 2025, 7:53 PM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $141.76 million as of June 27, 2025. Its market cap has decreased by -74.84% in one year.
Market Cap
141.76M
Enterprise Value
-93.95M
1-Year Change
-74.84%
Ranking
Category
Stock Price
$3.28
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $141.76M, a decrease of -84.22%. That is a compound annual growth rate of -73.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 141.76M | -12.20% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.97B |
| Johnson & Johnson | 365.27B |
| AbbVie | 329.30B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.72B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.75B |
| AstraZeneca | 216.45B |